Your Guide To Doctors, Health Information, and Better Health!
Your Health Magazine Logo
The following article was published in Your Health Magazine. Our mission is to empower people to live healthier.
Your Health Magazine
What is PDRN? The complete guide to skin regeneration’s most clinically advanced ingredient
Your Health Magazine
. http://yourhealthmagazine.net

What is PDRN? The complete guide to skin regeneration’s most clinically advanced ingredient

QUICK ANSWERPDRN (polydeoxyribonucleotide) is a purified DNA fragment derived from salmon, used in skincare to activate the A2A adenosine receptor pathway — a cellular mechanism that supports collagen synthesis, skin repair, and the reduction in the appearance of uneven skin tone. It is one of the few topical ingredients with verifiable ex vivo permeation data confirming its ability to reach deeper skin layers.

What exactly is PDRN?

PDRN stands for polydeoxyribonucleotide — a word built from three components: poly (many), deoxyribo (referring to deoxyribose, the sugar in DNA), and nucleotide (the building block of DNA). In plain terms, PDRN is a collection of short fragments of purified DNA.

These DNA fragments are not functional genetic material — they cannot alter your DNA or interfere with your cells’ genetic programming. Instead, they act as signalling molecules. When applied to skin (or injected in a clinical context), PDRN fragments are recognised by specific cell-surface receptors that trigger a cascade of repair and regeneration processes.

The molecular weight of PDRN fragments in well-formulated skincare products typically falls in the range of 50–50,000 Daltons, depending on the degree of fragmentation, with nano-encapsulated forms targeting the smaller end of this range to facilitate permeation across the skin barrier.

INCI NOTEOn ingredient lists, PDRN may appear as Sodium DNA, Polydeoxyribonucleotide Sodium, or simply PDRN. Nano-encapsulated versions may list additional carrier ingredients such as lecithin phospholipids. Always look for these names when evaluating a product.

How PDRN works at the cellular level

PDRN’s most significant mechanism is its interaction with the A2A adenosine receptor (A2AR) — a G protein-coupled receptor found on the surface of fibroblasts, keratinocytes, and macrophages in the skin.

When PDRN fragments bind to and activate the A2A receptor, several downstream effects are initiated:

  • Upregulation of VEGF (vascular endothelial growth factor) — supporting microcirculation and nutrient delivery to the dermis
  • Stimulation of fibroblast proliferation — increasing the population of cells responsible for producing collagen and elastin
  • Promotion of collagen type I and type III synthesis — both primary structural collagens that give skin its firmness and resilience
  • Anti-inflammatory signalling — A2A receptor activation is associated with reduced pro-inflammatory cytokine production, relevant for reactive or chronically stressed skin
  • Salvage pathway nucleotide recycling — PDRN fragments can be incorporated into the cell’s nucleotide salvage pathway, providing raw material for DNA repair in UV-damaged cells

How this differs from retinol and peptides

Retinol stimulates collagen synthesis by binding to nuclear retinoic acid receptors, but this pathway also increases cellular turnover and can cause irritation — particularly in Indian and South Asian skin with higher baseline inflammation sensitivity. Peptides act as messenger molecules that signal fibroblasts to produce collagen, but they do not address inflammatory signalling or DNA repair.

PDRN’s upstream receptor-level mechanism means it can support collagen synthesis, reduce the appearance of pigmentation irregularities, and modulate inflammation — without the irritation profile of retinol and without the purely surface-level action of most peptides.

Where does PDRN come from?

The most extensively studied and commercially established source of PDRN is salmon — specifically the DNA extracted from the sperm (milt) or roe of either Oncorhynchus mykiss (rainbow trout) or Oncorhynchus keta (Chum salmon).

Salmon DNA was selected for a practical reason: its nucleotide sequence is approximately 85% homologous to human DNA. This structural similarity allows salmon-derived PDRN to interact with human cell-surface receptors — particularly the A2A adenosine receptor — as effectively as it does. It is not the genetic sequence itself that matters; it is the molecular shape of the nucleotide fragments and their affinity for the receptor.

How PDRN is extracted and purified

  1. Isolation — DNA is extracted from salmon tissue under controlled conditions using physical disruption followed by enzymatic or chemical lysis
  2. Enzymatic fragmentation — long DNA strands are broken into shorter polydeoxyribonucleotide fragments using endonucleases, targeting specific molecular weight ranges
  3. Purification — protein, lipid, and cellular debris are removed through precipitation and filtration steps to yield a high-purity PDRN fraction
  4. Sterilisation — the final material is sterilised by autoclaving or filtration to ensure microbiological safety
  5. Salt conversion — in most cosmetic applications, PDRN is converted to its sodium salt form (Sodium DNA), which improves water solubility and formulation stability

The salmon used in PDRN production is sourced as a by-product of the food industry — the milt or roe that would otherwise be discarded during fish processing. No salmon are specifically raised or harvested for PDRN extraction. PDRN is, however, an animal-derived ingredient and is therefore not vegan.

What does the science actually show?

PDRN has an unusually strong evidence base for a topical skincare ingredient — partly because it migrated from injectable aesthetic medicine, where clinical data requirements are higher, and partly because a small number of brands have commissioned formulation-level permeation testing that goes beyond typical cosmetic industry standards.

The permeation data: what Franz diffusion shows

One of the most legitimate criticisms of any topical active is: does it actually get through the skin barrier? The stratum corneum is an effective barrier, and many ingredients that work beautifully in cell-based tests fail to demonstrate real-world relevance because they cannot cross it.

To answer this question, Boldpurity commissioned a Franz diffusion ex vivo skin permeation study conducted under OECD Test Guideline 428 by ACME Research Solutions, Meerut. The key finding: PDRN permeation was confirmed with a lag time of approximately 23 minutes — meaning meaningful PDRN transfer across the skin membrane begins within approximately 23 minutes of application.

† Ex vivo Franz diffusion study (OECD TG 428). ACME Research Solutions, Meerut. Conducted on excised human skin membrane using the SkinReset™ PDRN Serum formulation. Results reflect ex vivo conditions.

~23 minPDRN permeation lag timeEx vivo Franz diffusion · OECD TG 428 · ACME Research Solutions+41–43%Collagen stimulation vs untreated controlIn vitro HDF cell study · ISO 10993-5 · Invitra
46.1%Reduction in melanin appearance (treated cells)Ex vivo study · ACME Research Solutions~2×Tyrosinase inhibition vs niacinamide benchmark27.8% inhibition · Ex vivo data

The collagen stimulation evidence

In a Human Dermal Fibroblast (HDF) cell-based study conducted by Invitra, India, under ISO 10993-5 standards, the SkinReset™ PDRN Serum formulation demonstrated a 41–43% increase in collagen production in treated cells compared to untreated controls.

This is formulation-level data — tested on the actual serum in its commercial form, not on isolated PDRN as a raw material. The distinction matters: many brands cite raw material supplier data tested under laboratory concentrations that may differ significantly from what is in the final product.

The melanin and pigmentation data

The same ex vivo study recorded a 46.1% reduction in melanin appearance and 27.8% tyrosinase inhibition — approximately twice the tyrosinase inhibitory activity observed with niacinamide at standard use concentrations.

Tyrosinase is the primary enzyme responsible for melanin synthesis. Inhibiting it is the same mechanism targeted by established ingredients like kojic acid and arbutin. The fact that PDRN achieves this alongside collagen stimulation makes it particularly efficient for Indian skin concerns where both hyperpigmentation and loss of firmness coexist.

† All percentage figures refer to in vitro or ex vivo measurement and represent the appearance of change vs control. They do not constitute a claim to treat or cure any medical condition.

PDRN in clinic vs PDRN in skincare

PDRN was first used in Italy in the 1980s as an injectable wound-healing agent. It entered Korean aesthetic medicine as a skin booster injection in the early 2000s, and from there moved into topical skincare — first through Korean brands, and now increasingly through Indian brands with formulation capabilities.

FeatureInjectable PDRN (clinical)Topical PDRN (skincare)
Delivery methodIntradermal / subcutaneous injectionTopical application — serum, ampoule
PDRN concentrationTypically 2–8 mg/ml in solutionPremium formulations: 2,000–5,000 PPM
Permeation barrierBypassed entirely (injected)Must cross stratum corneum — delivery system critical
Cost per treatment (India)₹8,000–20,000 per session₹3,000–5,000 per bottle (~60–90 day supply)
Downtime24–72 hours (redness at injection site)None — continue normal routine
Who administersDermatologist / trained aestheticianSelf-administered at home
Evidence baseExtensive clinical trial literatureFranz diffusion + HDF cell data available
Daily useNot applicable (clinic sessions)Designed for daily application
IMPORTANT DISTINCTIONInjectable PDRN and topical PDRN are not direct substitutes. Injectable treatments deliver PDRN directly to the dermis, bypassing the skin barrier entirely. Topical formulations must first cross the stratum corneum — which is why delivery systems (nano-encapsulation, spicule-assisted permeation) are so important, and why permeation data matters more for topical PDRN than almost any other claim a brand can make.

Who is PDRN for?

Mature skin (35+) concerned about firmness

Collagen production declines at approximately 1% per year after the age of 25, with acceleration after 35 in women due to declining oestrogen. PDRN’s fibroblast-stimulating mechanism is directly relevant here — it supports the skin’s own collagen synthesis pathways rather than attempting to deliver collagen exogenously, as topical collagen creams do with limited effect due to molecular size.

Indian and South Asian skin with post-inflammatory hyperpigmentation

Fitzpatrick skin types IV–VI, which are most common across South Asia, have higher baseline melanin levels and a stronger tendency to hyperpigmentation in response to inflammation, UV exposure, or trauma. PDRN addresses this through its tyrosinase-inhibiting activity and its anti-inflammatory A2A receptor effect that reduces the inflammatory trigger in the first place.

Reactive or sensitised skin that cannot tolerate retinol

Retinol causes purging, peeling, and persistent dryness in a significant proportion of Indian users. PDRN delivers comparable collagen-supporting and pigmentation-modulating effects through a different, receptor-mediated pathway with no irritation potential.

Anyone maintaining results between clinical treatments

PDRN serum used between laser sessions, chemical peels, or injectable skin booster treatments can support the skin’s repair response and extend the duration of clinical results.

How to use PDRN serum in your routine

Evening routine (primary use)

  1. Cleanse — remove makeup, sunscreen, and daily buildup
  2. Tone/prep — if using a bubble toner or prep serum, apply now
  3. Targeted actives — if using a microneedling serum, apply before PDRN for maximum delivery benefit
  4. Apply PDRN serum — 3–4 drops pressed (not rubbed) gently into skin; allow 30–60 seconds for initial absorption
  5. Moisturise — seal the routine with your moisturiser to reduce transepidermal water loss overnight

The protocol above is based on how SkinReset™ PDRN Serum by Boldpurity® is designed to be used — nano-encapsulated Sodium DNA at 3,000 PPM, formulated for daily application and verified for dermal permeation under OECD TG 428.

Results timeline

  • 4–6 weeks: improvements in skin texture, radiance, and hydration
  • 8–12 weeks: improvements in the appearance of firmness and fine lines
  • 12 weeks minimum: realistic timeline for visible improvement in hyperpigmented marks

PDRN can also be used in the morning, before SPF. Note that PDRN does not replace sunscreen — daily broad-spectrum SPF 50 is the single most important step in managing hyperpigmentation concerns, and PDRN’s skin tone–evening effects will be significantly diminished without consistent UV protection.

Scientific references

1. Thellung S. et al. (1999). Polydeoxyribonucleotides promote the proliferation of human skin fibroblasts. Journal of Cellular Physiology.  PubMed ↗

2. Guizzardi S. et al. (2003). Polydeoxyribonucleotide promotes endothelial cell proliferation. Journal of Dermatological Science.  PubMed ↗

3. Bitto A. et al. (2011). PDRN reduces TGF-β1 and oxidative stress via A2A receptor activation. Journal of Vascular Surgery.  PubMed ↗

4. Gentile P. et al. (2019). Polydeoxyribonucleotides (PDRN) as growth factor in skin regeneration. Current Pharmaceutical Biotechnology.  PubMed ↗

5. OECD Test Guideline 428: Skin Absorption — In Vitro Method.  OECD.org ↗

6. Boldpurity® Internal Study Data (2025). PDRN ex vivo skin permeation (OECD TG 428) and HDF collagen stimulation (ISO 10993-5). ACME Research Solutions, Meerut & Invitra, India.

About the author

Khatija  is an Internationally certified cosmetic scientist with IFSCC-affiliated training from Australia. She is the formulation lead and co-founder of Boldpurity®, a cGMP-certified luxury clinical skincare brand based in Hyderabad, India. She personally formulates every product in the Boldpurity range. For media enquiries: care@boldpurity.com

This article is submitted for editorial consideration and is the original work of the named author. All clinical data cited refers to in vitro or ex vivo studies. Content does not constitute medical advice.

www.yourhealthmagazine.net
MD (301) 805-6805 | VA (703) 288-3130